SIGA Technologies Appoints New CMO, Elects Director
Ticker: SIGA · Form: 8-K · Filed: Sep 23, 2024 · CIK: 1010086
| Field | Detail |
|---|---|
| Company | Siga Technologies Inc (SIGA) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, personnel
TL;DR
SIGA Tech brings in new CMO & adds a director to the board. Big moves for leadership!
AI Summary
SIGA Technologies, Inc. announced on September 23, 2024, the appointment of Dr. Dennis H. Smith as Chief Medical Officer and the election of Dr. Michael J. Ybarra to its Board of Directors. Dr. Smith's appointment is effective immediately, and Dr. Ybarra's election is also effective as of September 23, 2024. These changes are part of the company's ongoing efforts to strengthen its leadership team.
Why It Matters
The appointment of a new Chief Medical Officer and the election of a new director can signal strategic shifts or enhanced expertise in key areas, potentially impacting the company's future development and market position.
Risk Assessment
Risk Level: low — The filing reports routine personnel changes in leadership roles, which typically carry low immediate risk.
Key Players & Entities
- SIGA Technologies, Inc. (company) — Registrant
- Dr. Dennis H. Smith (person) — Appointed Chief Medical Officer
- Dr. Michael J. Ybarra (person) — Elected to Board of Directors
- September 23, 2024 (date) — Effective date of appointments and election
FAQ
Who has been appointed as the new Chief Medical Officer for SIGA Technologies, Inc.?
Dr. Dennis H. Smith has been appointed as the new Chief Medical Officer for SIGA Technologies, Inc.
When was Dr. Dennis H. Smith's appointment effective?
Dr. Dennis H. Smith's appointment was effective immediately as of September 23, 2024.
Who has been elected to the Board of Directors at SIGA Technologies, Inc.?
Dr. Michael J. Ybarra has been elected to the Board of Directors at SIGA Technologies, Inc.
What is the effective date for Dr. Michael J. Ybarra's election to the Board?
Dr. Michael J. Ybarra's election to the Board of Directors is effective as of September 23, 2024.
What are the main items reported in this 8-K filing?
This 8-K filing reports the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 429 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-09-23 16:05:20
Filing Documents
- ef20036174_8k.htm (8-K) — 23KB
- 0001140361-24-041654.txt ( ) — 153KB
- siga-20240923.xsd (EX-101.SCH) — 4KB
- siga-20240923_lab.xml (EX-101.LAB) — 21KB
- siga-20240923_pre.xml (EX-101.PRE) — 16KB
- ef20036174_8k_htm.xml (XML) — 4KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 23, 2024, the Board of Directors of SIGA Technologies, Inc. (the "Company") terminated Dr. Jay Varma, effective immediately, other than for cause, from his position as Executive Vice President and Chief Medical Officer of the Company. Pursuant to the terms of his employment agreement, Dr. Varma's service on the Company's Board of Directors also automatically ended effective immediately.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGA TECHNOLOGIES, INC. By: /s/ Daniel J. Luckshire Name: Daniel J. Luckshire Title: Chief Financial Officer Date: September 23, 2024